Rigel Pharmaceuticals has seen its fair value estimate nudged up from US$49.60 to US$51.20, with only a small adjustment to the discount rate from 7.12% to 7.14% and revenue growth assumptions kept at ...
LOUISVILLE, Ky., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Onco360 ®, the nation’s leading independent specialty pharmacy, has been chosen by Rigel Pharmaceuticals as limited distribution specialty pharmacy ...
Over the last month the Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) has been much stronger than before, rebounding by 64%. But that can't change the reality that over the longer term (five years), the ...
SOUTH SAN FRANCISCO, Calif., Dec. 7, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today ...
Shares of Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) made a solid gain to kick off the week after the company gave an update on one of its clinical programs. Specifically, the firm provided more ...
SOUTH SAN FRANCISCO, Calif., Dec. 1, 2022 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that the U.S. Food and Drug Administration (FDA) has approved REZLIDHIA™ ...
One of the prettiest stars in the winter evening sky has to be Rigel, the bright blue-white “foot” of the constellation Orion the Hunter. Actually, it is hard to say which is the prettiest star. After ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback